PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12651350

Passive nighttime warming facility for forest ecosystem research.

R. J. Luxmoore·P. J. Hanson·J. J. Beauchamp·J. D. Joslin
View original source ↗Export metadata ↓

Abstract

A nighttime warming experiment is proposed. Over the last four decades a significant rise in nighttime minimum temperature has been determined from analysis of meteorological records from a global distribution of locations. The experiment involves nighttime deployment of infrared (IR) reflecting curtains around four sides of a forest canopy and across the top of the forest to mimic the top-down warming effect of cloud cover. The curtains are deployed with cable and pulley systems mounted on a tower and scaffolding structure built around the selected forest site. The trunk space is not enclosed except as an optional manipulation. The curtains reflect long-wave radiation emitted from the forest and ground back into the forest warming the trees, litter, and soil. Excellent infrared reflection can be obtained with commercially available fabrics that have aluminum foil bonded to one side. A canopy warming of 3 to 5 degrees C is expected on cloudless nights, and on cloudy nights, a warming of 1 to 3 degrees C is anticipated relative to a control plot. The curtains are withdrawn by computer control during the day and also at night during periods with precipitation or excessive wind. Examples of hypothesized ecosystem responses to nighttime warming include: (1) increase in tree maintenance respiration (decreasing carbon reserves and ultimately tree growth), (2) increase in the length of the growing season (increasing growth), (3) increase in soil respiration, (4) increase in litter decomposition, (5) increase in mineralization of N and other nutrients from soil organic matter, (6) increase in nutrient uptake (increasing growth), and (7) increase in N immobilization in litter. Hypothesis 1 has the opposite consequence for tree growth to Hypotheses 2 and 6, and thus opposite consequences for the feedback regulation that vegetation has on net greenhouse gas releases to the atmosphere. If Hypothesis 1 is dominant, warming could lead to more warming from the additional CO(2) emissions. Site-specific meteorological, ecophysiological, and phenological measurements are obtained in the warming treatment and in a carefully selected control plot to investigate site-specific hypotheses. Measurements made on both plots for a baseline period and during the period of curtain deployment provide data to test the hypotheses statistically by the "before-after-control-impact" method applicable to unreplicated experiments. The enclosure has a modular design that can be adapted and combined with other forest-scale manipulation experiments such as free air CO(2) enrichment and throughfall displacement.

Explore related subjects

Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R. J. Luxmoore, P. J. Hanson, J. J. Beauchamp, J. D. Joslin. Passive nighttime warming facility for forest ecosystem research.. https://doi.org/10.1093/treephys%2F18.8-9.615

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗